Shintaro Nagashima

3 ta ish

Hiroshima University

1. Seroepidemiological study of factors affecting anti-spike IgG antibody titers after a two-dose mRNA COVID-19 vaccination in 3744 healthy Japanese volunteers

   Aya Sugiyama, Akemi Kurisu, Shintaro Nagashima +13

   MaqolaOAOchiq kirishSARS-CoV-2 and COVID-19 ResearchScientific Reports20221 iqtibos

   ABIABI:AkademIndex/2022.article.000606

2. Eighteen‐year follow‐up cohort study on hepatitis B and C virus infections related long‐term prognosis among hemodialysis patients in Hiroshima

   Ko Ko, Shintaro Nagashima, Chikako Yamamoto +9

   MaqolaHepatitis B Virus StudiesJournal of Medical Virology20200 iqtibos

   ABIABI:AkademIndex/2020.article.000690

3. Author Correction: Seroepidemiological study of factors affecting anti-spike IgG antibody titers after a two-dose mRNA COVID-19 vaccination in 3744 healthy Japanese volunteers

   Aya Sugiyama, Akemi Kurisu, Shintaro Nagashima +13

   BoshqaOAOchiq kirishImmunotherapy and Immune ResponsesScientific Reports20230 iqtibos

   ABIABI:AkademIndex/2023.other.000020